BR9711338A - Formula-{es de cidos quiolanacarboxilicos ou cidos naftorodonacarboxilicos oralmente administr veis - Google Patents

Formula-{es de cidos quiolanacarboxilicos ou cidos naftorodonacarboxilicos oralmente administr veis

Info

Publication number: BR9711338A
Authority: BR; Brazil
Prior art keywords: acid; naphthorodonacarboxylic; chiolanacarboxylic; orally administrable; formulations
Prior art date: 1996-08-20

Application number

BR9711338A

Other languages

English (en)

Other versions

BR9711338B1 (pt

Inventor

Oliver Vetter

Reinhold Loehr

Matthias Kuhn

Hubert Rast

Ernst Heinen

Martin Scheer

Francisco Cabrera

Original Assignee

Bayer Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-08-20

Filing date

1997-08-07

Publication date

1999-08-17

1997-08-07 Application filed by Bayer Ag filed Critical Bayer Ag

1999-08-17 Publication of BR9711338A publication Critical patent/BR9711338A/pt

2009-01-13 Publication of BR9711338B1 publication Critical patent/BR9711338B1/pt

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Tropical Medicine & Parasitology (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

BRPI9711338-7A 1996-08-20 1997-08-07 processo para preparaÇço de formulaÇÕes de Ácidos quinolonacarboxÍlicos ou Ácidos naftiridonacarboxÍlicos oralmente administrÁveis, produto granular assim obtido, bem como composiÇço que o contÉm. BR9711338B1 (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE19633480A DE19633480A1 (de)	1996-08-20	1996-08-20	Oral applizierbare Formulierungen von Chinolon- und Naphthyridoncarbonsäuren
PCT/EP1997/004302 WO1998007428A1 (de)	1996-08-20	1997-08-07	Oral applizierbare formulierungen von chinolon- oder naphthyridoncarbonsäuren

Publications (2)

Publication Number	Publication Date
BR9711338A true BR9711338A (pt)	1999-08-17
BR9711338B1 BR9711338B1 (pt)	2009-01-13

Family

ID=7803084

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI9711338-7A BR9711338B1 (pt)	1996-08-20	1997-08-07	processo para preparaÇço de formulaÇÕes de Ácidos quinolonacarboxÍlicos ou Ácidos naftiridonacarboxÍlicos oralmente administrÁveis, produto granular assim obtido, bem como composiÇço que o contÉm.

Country Status (16)

Country	Link
US (1)	US5808076A (pt)
EP (1)	EP0920317B1 (pt)
JP (1)	JP4338222B2 (pt)
KR (1)	KR100493577B1 (pt)
CN (1)	CN1113651C (pt)
AR (1)	AR008304A1 (pt)
AT (1)	ATE260657T1 (pt)
AU (1)	AU3942797A (pt)
BR (1)	BR9711338B1 (pt)
CA (1)	CA2263584C (pt)
DE (2)	DE19633480A1 (pt)
DK (1)	DK0920317T3 (pt)
ES (1)	ES2213829T3 (pt)
MY (1)	MY117606A (pt)
TW (1)	TW518226B (pt)
WO (1)	WO1998007428A1 (pt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR100365679B1 (ko) *	2000-04-03	2002-12-26	주식회사 엘지생명과학	기호성이 우수한 엔로프록사신 프리믹스 조성물 및 그제조방법
US6518252B2 (en) *	2000-09-20	2003-02-11	University Of Georgia Research Foundation, Inc.	Method of treating aquatic animals with an antimicrobial agent and chelating agent
US20020122824A1 (en) *	2001-01-24	2002-09-05	Francisco Cabrera	Solid phase dispersion of quinolone-or naphthyridonecarboxylic acids
US6589955B2 (en)	2001-06-20	2003-07-08	Bristol-Myers Squibb Company	Pediatric formulation of gatifloxacin
WO2003031443A1 (en) *	2001-10-04	2003-04-17	Morphochem Aktiengesellschaft für kombinatorische Chemie	Dual actions antibiotics comprising a oxazoldinone and a quinolone or naphthyridinone moiety
RU2373937C9 (ru) *	2003-02-10	2010-07-27	Байер Шеринг Фарма Акциенгезельшафт	Лечение бактериальных заболеваний органов дыхания путем местного применения фторхинолонов
DE602004014361D1 (de)	2003-04-30	2008-07-24	Morphochem Ag Komb Chemie	Verwendung von oxazolidinon-chinolin-hybrid-antibiotika zur behandlung von anthrax und anderen infektionen
DE10328666A1 (de) *	2003-06-26	2005-01-13	Bayer Healthcare Ag	Tabletten enthaltend Geschmacks-und/oder Aromastoffe
DE10337191A1 (de) *	2003-08-13	2005-03-17	Bayer Healthcare Ag	Neue Verwendung von Chinolon-Antibiotika
DE10340485B4 (de) *	2003-09-03	2015-05-13	Morphochem AG Aktiengesellschaft für kombinatorische Chemie	Verfahren zur Herstellung von Oxazolidinon-Chinolon Hybriden
DE10351448A1 (de) *	2003-11-04	2005-06-09	Bayer Healthcare Ag	Geschmackstoffhaltige Arzneimittelformulierungen mit verbesserten pharmazeutischen Eigenschaften
JP2007516263A (ja)	2003-12-18	2007-06-21	モルフォケムアクチェンゲゼルシャフトフュアコンビナトリシェヘミー	オキサゾリジノン−キノロンハイブリッド抗生物質
US8158797B2 (en) *	2003-12-18	2012-04-17	Morphochem Aktiengesellschaft Fur Kombinatorische Chemie	Oxazolidinone-quinolone hybrid antibiotics
FR2896416B1 (fr) *	2006-01-24	2010-08-13	Vetoquinol	Composition anti-infectieuse comprenant un compose de type pyrido (3,2,1-ij)-benzoxadiazine
CN100360131C (zh) *	2006-01-24	2008-01-09	新昌国邦化学工业有限公司	一种掩味恩诺沙星的生产方法
WO2008151502A1 (fr) *	2007-06-08	2008-12-18	Hainapharm Pharmaceutical Co., Ltd. Foshan	Formulation de microcapsules d'enrofloxacine et son procédé de préparation
EP2343089A4 (en)	2008-09-23	2013-05-01	Jaer S A Lab	USE OF XYLITOL OR DERIVATIVES THEREOF FOR MASKING THE TASTE OF CHEMOTHERAPEUTIC MEDICAMENTS OF THE CHINOLO-N-NAPHTHYRIDONE-CARBOXYLIC ACID GROUP FOR PIG DICULTINATION
EP2983788A1 (en) *	2013-04-09	2016-02-17	Cresset Biomolecular Discovery Limited	The local treatment of inflammatory ophthalmic diseases
CN103251552B (zh) *	2013-05-30	2014-12-31	成都乾坤动物药业有限公司	一种恩诺沙星糊剂及其制备方法
CN119732954A (zh) *	2025-03-04	2025-04-01	深圳国家感染性疾病临床医学研究中心	恩诺沙星在制备耐药菌抑菌剂和制备治疗结核病的药物中的应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NL266216A (pt) *	1960-07-12
GB1174221A (en) *	1968-01-08	1969-12-17	Ici Ltd	Acid-addition Salts of Tetramisole
CH524372A (de) *	1969-01-29	1972-06-30	Ciba Geigy Ag	Verfahren zur Herstellung von stabilen Elixieren, welche therapeutisch verwendbare tricyclische basische Wirkstoffe in Form ihrer Mononatriumpamoate enthalten
DE3525335A1 (de) *	1985-07-16	1987-01-22	Bayer Ag	Embonate von chinoloncarbonsaeuren und ihren derivaten
JPS62192321A (ja) *	1986-02-19	1987-08-22	Bayer Japan Kk	魚類用抗菌剤
US5281596A (en) *	1986-02-19	1994-01-25	Bayer Aktiengesellschaft	Antibacterial drugs for fish
DE3719764A1 (de) *	1987-06-13	1988-12-22	Bayer Ag	Ionenaustauscherharze beladen mit chinoloncarbonsaeurederivaten, ihre herstellung und verwendung
US5232919A (en) *	1987-11-13	1993-08-03	Asta Pharma Aktiengesellschaft	Azelastine embonate and compositions which contain it
DE4032560A1 (de) *	1990-10-13	1992-04-16	Bayer Ag	7-(2,7-diazabicyclo(3.3.0)octyl)-3-chinolon- und -naphtyridoncarbonsaeure-derivate

1996
- 1996-08-20 DE DE19633480A patent/DE19633480A1/de not_active Withdrawn
- 1996-12-06 US US08/761,687 patent/US5808076A/en not_active Expired - Lifetime
1997
- 1997-08-07 EP EP97936690A patent/EP0920317B1/de not_active Expired - Lifetime
- 1997-08-07 KR KR10-1999-7000990A patent/KR100493577B1/ko not_active Expired - Fee Related
- 1997-08-07 WO PCT/EP1997/004302 patent/WO1998007428A1/de not_active Ceased
- 1997-08-07 BR BRPI9711338-7A patent/BR9711338B1/pt not_active IP Right Cessation
- 1997-08-07 JP JP51033898A patent/JP4338222B2/ja not_active Expired - Fee Related
- 1997-08-07 CN CN97197362A patent/CN1113651C/zh not_active Expired - Fee Related
- 1997-08-07 ES ES97936690T patent/ES2213829T3/es not_active Expired - Lifetime
- 1997-08-07 DE DE59711379T patent/DE59711379D1/de not_active Expired - Lifetime
- 1997-08-07 CA CA002263584A patent/CA2263584C/en not_active Expired - Fee Related
- 1997-08-07 AU AU39427/97A patent/AU3942797A/en not_active Abandoned
- 1997-08-07 AT AT97936690T patent/ATE260657T1/de not_active IP Right Cessation
- 1997-08-07 DK DK97936690T patent/DK0920317T3/da active
- 1997-08-11 MY MYPI97003670A patent/MY117606A/en unknown
- 1997-08-15 TW TW086111729A patent/TW518226B/zh not_active IP Right Cessation
- 1997-08-19 AR ARP970103769A patent/AR008304A1/es active IP Right Grant

Also Published As

Publication number	Publication date
CN1228023A (zh)	1999-09-08
JP2000516239A (ja)	2000-12-05
DE59711379D1 (de)	2004-04-08
MY117606A (en)	2004-07-31
DE19633480A1 (de)	1998-02-26
HK1022435A1 (en)	2000-08-11
KR100493577B1 (ko)	2005-06-10
US5808076A (en)	1998-09-15
CA2263584C (en)	2008-12-23
AR008304A1 (es)	1999-12-29
DK0920317T3 (da)	2004-07-05
ES2213829T3 (es)	2004-09-01
JP4338222B2 (ja)	2009-10-07
CN1113651C (zh)	2003-07-09
AU3942797A (en)	1998-03-06
EP0920317B1 (de)	2004-03-03
CA2263584A1 (en)	1998-02-26
EP0920317A1 (de)	1999-06-09
TW518226B (en)	2003-01-21
ATE260657T1 (de)	2004-03-15
KR20000068070A (ko)	2000-11-25
BR9711338B1 (pt)	2009-01-13
WO1998007428A1 (de)	1998-02-26

Publication	Publication Date	Title
BR9711338A (pt)	1999-08-17	Formula-{es de cidos quiolanacarboxilicos ou cidos naftorodonacarboxilicos oralmente administr veis
PT769965E (pt)	2002-04-29	Formulacoes aquosas de risperidona
DE69703385D1 (de)	2000-11-30	Alkoxyessigsäure-derivate
NO990821D0 (no)	1999-02-22	Arylsulfonylamino-hydroksaminsyre-derivater
BR9510256A (pt)	1997-11-04	Derivados de ácido 3-aril-tetrônico
FI944800A0 (fi)	1994-10-12	Indoli-2-karboksyylihappojohdannaisia
DE69518331D1 (de)	2000-09-14	Orale zubereitungen
FI950910A0 (fi)	1995-02-28	Rasvahappojohdannaiset
TR199501137A2 (tr)	1996-06-21	Terapötik olarak aktif bilesenler
FI951962A7 (fi)	1995-10-26	Hydroksaamihappojohdannaiset
DE69228301D1 (de)	1999-03-11	Hochsteifigkeitschaftfräser
ATE255117T1 (de)	2003-12-15	Aminophosphonsäure-derivate als arzneimittel
FI933424A7 (fi)	1994-02-01	Peptidyyli-4-amino-2,2-difluori-3-okso-1,6-heksaanidinihappojohdannaiset tulehdusta vastustavina aineina
FI950909A7 (fi)	1995-09-02	Rasvahappojohdannaisia
ATE263550T1 (de)	2004-04-15	Orale cyclosporinformulierungen
ID16781A (id)	1997-11-13	Formulasi-formulasi farmasi
DE59707658D1 (de)	2002-08-08	Glyoxylsäure-derivate
DE69718338D1 (de)	2003-02-13	3-alkoxyisoxazol-4-yl-substituierte 2-aminocarbonsäurederivate
DE69432149D1 (de)	2003-03-27	Orale Zubereitungen
DE59711741D1 (de)	2004-08-05	Bismuthvanadat-Pigmente
ITMI941169A0 (it)	1994-06-06	Formulazioni farmaceutiche
DE69317893D1 (de)	1998-05-14	Percarbonsäure
ATE219050T1 (de)	2002-06-15	Hydroxamsäure-derivate
NO981324D0 (no)	1998-03-24	Formuleringer omfattende 1,2,4-benzotriazinoksyder
BR9508824A (pt)	1998-05-19	Derivado de ácido imícido

Legal Events

Date	Code	Title	Description
2004-11-09	B06A	Patent application procedure suspended [chapter 6.1 patent gazette]
2005-03-22	B06A	Patent application procedure suspended [chapter 6.1 patent gazette]
2005-07-05	B06A	Patent application procedure suspended [chapter 6.1 patent gazette]
2006-01-24	B06A	Patent application procedure suspended [chapter 6.1 patent gazette]
2008-01-15	B06A	Patent application procedure suspended [chapter 6.1 patent gazette]
2008-09-02	B09A	Decision: intention to grant [chapter 9.1 patent gazette]
2009-03-10	B16A	Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]	Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 10/03/2009, OBSERVADAS AS CONDICOES LEGAIS.
2010-10-13	B25A	Requested transfer of rights approved	Owner name: BAYER ANIMAL HEALTH GMBH (DE) Free format text: TRANSFERIDO DE: BAYER AKTIENGESELLSCHAFT
2014-06-10	B21F	Lapse acc. art. 78, item iv - on non-payment of the annual fees in time	Free format text: REFERENTE A 17A ANUIDADE.
2015-11-24	B24J	Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)	Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2266 DE 10-06-2014 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.